RT @BJGPjournal: Newer long-acting insulin for patients with #diabetes are being prescribed at varying rates in general practice, despite D…
RT @BJGPjournal: Newer long-acting insulin for patients with #diabetes are being prescribed at varying rates in general practice, despite D…
Newer long-acting insulin for patients with #diabetes are being prescribed at varying rates in general practice, despite Dutch guidelines advising other intermediate or long-acting insulins for #T2DM https://t.co/USjsqOFplc @MedicijnBalans @medicijngebruik
RT @BJGPjournal: Diabetes: newer long-acting insulins for T2DM are being prescribed at varying rates in general practice, despite Dutch gui…
IVM-collega's Marloes Dankers en Marjorie Nelissen werkten en schreven mee aan dit onderzoek.
Newer long-acting #InsulinPrescriptions for patients with type 2 #diabetes: prevalence & practice variation in a retrospective cohort study https://t.co/jzJ0neJ5kh ✅Contact- [email protected]">@nelft.nhs.uk">[email protected] -for help with accessing this & thousands of other e
Diabetes: newer long-acting insulins for T2DM are being prescribed at varying rates in general practice, despite Dutch guidelines advising other intermediate or long-acting insulins https://t.co/USjsqOFplc @MedicijnBalans @medicijngebruik @nivel_research #